Clinica Baviera (ES:CBAV) has released an update.
Clínica Baviera has expanded its reach by acquiring the UK-based Optimax Group, with 19 clinics and a team of over 130, for approximately 11.7 million euros plus a variable amount tied to the Group’s future EBITDA. This strategic growth move marks the company’s entrance into the significant UK market, further solidifying its European presence.
For further insights into ES:CBAV stock, check out TipRanks’ Stock Analysis page.
